171 related articles for article (PubMed ID: 29320990)
1. Correlation between polymorphisms in toll-like receptor genes and the activity of hepatitis B virus among treatment-naïve patients: a case-control study in a Han Chinese population.
Lin Y; Gao ZX; Shen X; Chen MJ; Li YT; Li SL; Lin HL; Zhao QF; Liu F; Niu JJ
BMC Infect Dis; 2018 Jan; 18(1):28. PubMed ID: 29320990
[TBL] [Abstract][Full Text] [Related]
2. Interaction of TLR-IFN and HLA polymorphisms on susceptibility of chronic HBV infection in Southwest Han Chinese.
He D; Tao S; Guo S; Li M; Wu J; Huang H; Guo X; Yan G; Zhu P; Wang Y
Liver Int; 2015 Aug; 35(8):1941-9. PubMed ID: 25469587
[TBL] [Abstract][Full Text] [Related]
3. The Association between NFKBIA Polymorphisms and the Progression of Chronic Hepatitis B Virus Infection among the Chinese Han Population.
Lin Y; Su C; Niu J; Guo Z; Lu Y
Jpn J Infect Dis; 2018 Jan; 71(1):21-27. PubMed ID: 29093318
[TBL] [Abstract][Full Text] [Related]
4. Toll- like receptor 2 polymorphism and IL-6 profile in relation to disease progression in chronic HBV infection: a case control study in Egyptian patients.
Elbrolosy AM; Elabd NS; ElGedawy GA; Abozeid M; Abdelkreem M; Montaser B; Eed EM; Elhamouly MS
Clin Exp Med; 2023 Feb; 23(1):117-129. PubMed ID: 35119591
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor and hepatitis B virus clearance in chronic infected patients: a long-term prospective cohort study in Taiwan.
Wu JF; Chen CH; Ni YH; Lin YT; Chen HL; Hsu HY; Chang MH
J Infect Dis; 2012 Sep; 206(5):662-8. PubMed ID: 22740716
[TBL] [Abstract][Full Text] [Related]
6. Association between Interleukin-21 and Interleukin-21 receptor gene polymorphisms with susceptibility to chronic hepatitis B virus infection and HBV spontaneous clearance in Iranian population.
Shoraka S; Mohebbi SR; Hosseini SM; Hosseini Razavi A; Hatami Y; Sharifian A; Rostami-Nejad M; Asadzadeh Aghdaei H; Zali MR
Microb Pathog; 2019 Mar; 128():263-267. PubMed ID: 30639626
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of RIG-I-like receptor influence HBV clearance in Chinese Han population.
Yao Y; Shen Y; Shao H; Liu Y; Ji Y; Du G; Ye X; Huang P; Chen H
J Med Virol; 2021 Aug; 93(8):4957-4965. PubMed ID: 33783003
[TBL] [Abstract][Full Text] [Related]
8. Serum Toll-Like Receptor-2, Toll-Like Receptor-4 Levels in Patients with HBeAg-Negative Chronic Viral Hepatitis B.
Akbal E; Koçak E; Köklü S; Ergül B; Akyürek Ö; Yılmaz FM
Viral Immunol; 2017 May; 30(4):278-282. PubMed ID: 28414577
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the Toll-like receptor 3 (TLR3) gene are associated with the natural course of hepatitis B virus infection in Caucasian population.
Fischer J; Koukoulioti E; Schott E; Fülöp B; Heyne R; Berg T; van Bömmel F
Sci Rep; 2018 Aug; 8(1):12737. PubMed ID: 30143709
[TBL] [Abstract][Full Text] [Related]
10. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in Toll-like receptor 3 gene are associated with the risk of hepatitis B virus-related liver diseases in a Chinese population.
Huang X; Li H; Wang J; Huang C; Lu Y; Qin X; Li S
Gene; 2015 Sep; 569(2):218-24. PubMed ID: 26024592
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor-mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen.
Jiang M; Broering R; Trippler M; Poggenpohl L; Fiedler M; Gerken G; Lu M; Schlaak JF
J Viral Hepat; 2014 Dec; 21(12):860-72. PubMed ID: 24498958
[TBL] [Abstract][Full Text] [Related]
14. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
Cheong JY; Cho SW; Hwang IL; Yoon SK; Lee JH; Park CS; Lee JE; Hahm KB; Kim JH
J Gastroenterol Hepatol; 2006 Jul; 21(7):1163-9. PubMed ID: 16824070
[TBL] [Abstract][Full Text] [Related]
15. Association of a TANK gene polymorphism with outcomes of hepatitis B virus infection in a Chinese Han population.
Song QL; He XX; Yang H; Li J; Chen M; Wang MY; Liu Q; Yu JL; Yao JJ; Liu LF; Sun SZ; Lin JS
Viral Immunol; 2012 Feb; 25(1):73-8. PubMed ID: 22225470
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of interleukin-6 influence the development of hepatitis B virus-related liver cirrhosis in the Han Chinese population.
Xia C; Zhu W; Huang C; Lou G; Ye B; Chen F; Chen Z; Liu Y; Zheng M
Infect Genet Evol; 2020 Oct; 84():104331. PubMed ID: 32353512
[TBL] [Abstract][Full Text] [Related]
17. Association of polymorphisms in interleukin-18 and interleukin-28B with hepatitis B recurrence after liver transplantation in Chinese Han population.
Li Y; Shi Y; Chen J; Cai B; Ying B; Wang L
Int J Immunogenet; 2012 Aug; 39(4):346-52. PubMed ID: 22325058
[TBL] [Abstract][Full Text] [Related]
18. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
[TBL] [Abstract][Full Text] [Related]
19. Association between TNFAIP3 nonsynonymous single-nucleotide polymorphism rs2230926 and chronic hepatitis B virus infection in a Chinese Han population.
Zhang P; Li N; Zhu Q; Li F; Yang C; Zeng X; Lv Y; Zhou Z; Han Q; Liu Z
Virol J; 2015 Feb; 12():33. PubMed ID: 25890346
[TBL] [Abstract][Full Text] [Related]
20. The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes.
Song XM; Li QL; Guo F; Peng H; Guo JJ
Ann Hepatol; 2018 Oct; 17(6):940-947. PubMed ID: 30600290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
